Ilyda

Ilyda EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Ilyda (ILYDA.AT) as of Nov 3, 2026 is 26.52 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 29.36 % — a change of -9.69% (lower).

EBIT/Assets

26.52 %

YoY

-9.69%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Ilyda is 2025 26.52 % . Operating Income to Assets Ratio (EBIT/Assets) of Ilyda was 2024 29.36 % . It decreases by -9.69% lower compared to the previous year.

The Ilyda EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2018
-2.95 EUR
Jan 1, 2019
1.55 EUR
Jan 1, 2020
6.39 EUR
Jan 1, 2021
6.60 EUR
Jan 1, 2022
7.81 EUR
Jan 1, 2023
12.48 EUR
Jan 1, 2024
29.36 EUR
Jan 1, 2025
26.52 EUR
The Ilyda EBIT/Assets history
YEAREBIT/AssetsYoY
26.52 %-9.69%
29.36 %+135.34%
12.48 %+59.85%
7.81 %+18.26%
6.60 %+3.37%
6.39 %+311.84%
1.55 %-152.63%
-2.95 %-151.54%
5.72 %-223.27%
-4.64 %+281.86%
-1.21 %-81.19%
-6.45 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ilyda Stock analysis

What does Ilyda do? Ilyda SA develops software solutions including ERP systems and specialized vertical market applications. The company offers MegaTron ERP for business resource management, MegaTron Pharma for pharmacy warehouse management, VitaCard for consumer privileges, and payroll and personnel management software. Ilyda SA provides customer training, after-sales support, and maintenance services for its products. Enterprise clients such as retail chains, pharmacies, financial institutions, and public sector organizations purchase these software solutions and services. The company targets retail chains with point-of-sale programs, pharmacies using MegaTron Pharma, and financial institutions requiring tailored software. Public sector entities and educational institutions also buy Ilyda SA's customized applications. Ilyda SA generates revenue through the sale of its software products and associated support services for these specific market segments. MegaTron ERP, MegaTron Pharma, VitaCard, and payroll management systems are the core products sold to enterprise customers. Retail chains, pharmacies, banks, and public sector organizations represent the primary buyer segments. The company's revenue model combines product sales with ongoing service contracts for training and maintenance. Ilyda is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ilyda stock

Operating Income to Assets Ratio (EBIT/Assets) of Ilyda is 26.52 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of Ilyda changed from 29.36 % to 26.52 %, representing a -9.69% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Ilyda since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Ilyda with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Ilyda

All Key Metrics — Ilyda